Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITACAL: Tailored vs Conventional Vitamin D Supplementation in Breast Cancer
NCT01480869Phase 3Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in Vitamin D deficiency (VDD), sponsored by Institut du Cancer de Montpellier. Started Jul 2011; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01480869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480869.